Dashboard
Manage Tickers

PRPHProPhase Labs, Inc.

Nasdaq prophaselabs.com


$ 3.64 $ -0.17 (-4.47 %)    

Wednesday, 03-Jul-2024 12:54:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 3.63
$ 3.64
$ 0.00 x 0
$ 0.00 x 0
$ 3.64 - $ 3.64
$ 3.56 - $ 7.59
28,985
na
69.26M
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-19-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-20-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-28-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 02-24-2017 12-31-2016 10-K
31 11-15-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-29-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-13-2015 03-31-2015 10-Q
38 03-27-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

prophase-labs-q1-2024-gaap-eps-007-beats-018-estimate-sales-3634m-miss-9860m-estimate
ProPhase Labs Q1 2024 GAAP EPS $(0.07) Bea...
05/09/2024 12:02:27

ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.18)...

prophase-labs-unveils-project-zenq-ai-leveraging-prophase-labs-ai-platform-massive-genomics-database-and-patented-esophageal-cancer-insights-for-antibody-drug-conjugates-development
ProPhase Labs Unveils Project ZenQ-AI; Lev...
04/16/2024 12:15:30

Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug ...

prophase-labs-seeks-to-transform-esophageal-cancer-detection-and-management-with-launch-of-its-be-smart-test-in-h2-2024
ProPhase Labs Seeks To Transform Esophagea...
04/10/2024 12:09:13

ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagn...

prophase-labs-q4-eps-051-misses-026-estimate-sales-435m-miss-1069m-estimate
ProPhase Labs Q4 EPS $(0.51) Misses $(0.26...
03/15/2024 12:10:26

ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.2...

earnings-scheduled-for-march-15-2024
Earnings Scheduled For March 15, 2024
03/15/2024 09:15:18

Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on re...

prophase-labss-earnings-a-preview
ProPhase Labs's Earnings: A Preview
03/14/2024 15:00:40

hc-wainwright--co-reiterates-buy-on-prophase-labs-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on ProP...
02/21/2024 18:20:13

HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $11 price target.

prophase-labs-announces-progress-in-be-smart-esophageal-cancer-test-development-uspto-grants-additional-broad-patents-for-be-smart
ProPhase Labs Announces Progress In BE-Sma...
02/20/2024 13:19:22

ProPhase Labs, Inc. (NASDAQ:PRPH), a next generation biotech, genomics and diagnostics company, today announced important devel...

prophase-labs-announces-preliminary-results-for-dietary-supplement-equivir-co-says-prelim-results-indicate-it-has-the-potential-to-support-and-maintain-immunity
ProPhase Labs Announces Preliminary Result...
02/14/2024 13:11:10

prophase-labs-announces-progress-at-pharmaloz-manufacturing-accelerating-expansion-improves-pricing-boosts-profitability-and-secures-new-contracts
ProPhase Labs Announces Progress At Pharma...
01/23/2024 13:19:21

Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCo...

prophase-poised-to-ramp-up-growth-at-pharmaloz-and-nebula-genomics-in-2024-company-announces-the-hiring-of-long-time-industry-veteran-jed-latkin-as-coo-to-help-build-and-manage-this-growth
Prophase Poised To Ramp Up Growth At Pharm...
01/04/2024 13:14:43

Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time indust...

hc-wainwright--co-maintains-buy-on-prophase-labs-lowers-price-target-to-11
HC Wainwright & Co. Maintains Buy on ProPh...
11/10/2023 15:27:51

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $1...

prophase-labs-q3-eps-030-misses-020-estimate-sales-837m-miss-1306m-estimate
ProPhase Labs Q3 EPS $(0.30) Misses $(0.20...
11/09/2023 13:01:29

ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.2...

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

prophase-labs-earnings-preview
ProPhase Labs Earnings Preview
11/08/2023 17:01:29

prophase-labs-inc-says-pharmaloz-plan-is-to-build-capacity-with-a-goal-to-attain-a-revenue-run-rate-of-60-to-80m-by-year-end-2024-pharmaloz-is-projected-to-achieve-a-run-rate-of-15m-in-annualized-revenues--run-rate-of-3m-in-gross-profit-during-q1
Prophase Labs Inc Says Pharmaloz Plan Is T...
10/17/2023 12:12:56

- Reuters

Core News & Articles
DSS Inc. Issues Letter To Shareholders Pro...
10/12/2023 12:28:44

DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisi...

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
08/29/2023 18:37:27

  On Tuesday, 99 stocks hit new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
08/28/2023 17:54:09

  During Monday, 102 stocks hit new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
08/14/2023 17:48:47

  During Monday's session, 201 stocks hit new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)